Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05349682 · ClinicalTrials.gov registry record · NA

Bayer OA Knee Pain Pilot

A NA study of Osteoarthritis, Knee, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05349682: Recruiting NA study of Osteoarthritis, Knee, sponsored by Medical University of South Carolina.

NCT05349682 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 12 participants, below the 498-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05349682, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to investigate if MRI can be used to evaluated effect of knee artery embolization for knee osteoarthritis. Participants be evaluated in clinic, obtain a knee MRI, undergo embolization of the symptomatic knee, and follow up in clinic at 1, 6, and 12 months after embolization. A second MRI is obtained 6 months after embolization. Participants will keep a record of their pain level and treatment and answer questionnaires at each visit. In addition, this study aims to determine the effects of knee artery embolization on the amount of opioid (pain reliever drugs) needed to manage osteoarthritis-associated pain and change in quality of life.

Primary Outcome

To evaluate the effects of particle embolization on knee osteoarthritis progression using enhancement time intensity curves obtained from CE-MRI (Contrast Enhanced Magnetic Resonance Imaging)

Conditions Studied

Osteoarthritis, Knee

Interventions

  • DIAGNOSTIC_TEST dynamic contrast enhanced MRI
  • PROCEDURE geniculate artery embolization

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-10-01
Est. Completion 2026-06
Phase NA
Medical University of South Carolina

755 total trials

What NCT05349682 shows while recruiting

NCT05349682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 498-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which dynamic contrast enhanced MRI is the first listed.

NCT05349682 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT05349682 about?

NCT05349682 is a clinical study titled "Bayer OA Knee Pain Pilot". The objective of this study is to investigate if MRI can be used to evaluated effect of knee artery embolization for knee osteoarthritis. Participants be evaluated in clinic, obtain a knee MRI, undergo embolization of the symptomatic knee, and follow up in clinic at 1, 6, and 12 months after emboliz...

What is the current status of trial NCT05349682?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2022-10-01. Estimated completion is 2026-06.

What conditions does trial NCT05349682 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT05349682?

The interventions under investigation include: dynamic contrast enhanced MRI (DIAGNOSTIC_TEST), geniculate artery embolization (PROCEDURE).

Who is sponsoring clinical trial NCT05349682?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05349682 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05349682's enrollment target sits among peer trials

12 109th of 112 higher than 4 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05349682

Source: ClinicalTrials.gov NCT05349682, the US trial registry maintained by the National Library of Medicine. NCT05349682 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.